kn 04 has been researched along with pyridoxal phosphate in 2 studies
| Studies (kn 04) | Trials (kn 04) | Recent Studies (post-2010) (kn 04) | Studies (pyridoxal phosphate) | Trials (pyridoxal phosphate) | Recent Studies (post-2010) (pyridoxal phosphate) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 6,511 | 140 | 860 |
| Protein | Taxonomy | kn 04 (IC50) | pyridoxal phosphate (IC50) |
|---|---|---|---|
| P2X purinoceptor 1 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chessell, IP; Humphrey, PP; Kaur, R; Michel, AD | 1 |
| Kimura, J; Matsuoka, I; Watano, T | 1 |
2 other study(ies) available for kn 04 and pyridoxal phosphate
| Article | Year |
|---|---|
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antibodies, Blocking; Benzoxazoles; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Inhibitors; Fluorescent Dyes; Humans; Imidazoles; In Vitro Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Stimulation, Chemical | 2000 |
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Benzoxazoles; Cations; Cell Membrane Permeability; Fluorescent Dyes; Mice; Patch-Clamp Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Suramin; Triazines; Tumor Cells, Cultured | 2002 |